EE05644B1 - Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG - Google Patents

Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG

Info

Publication number
EE05644B1
EE05644B1 EEP200200469A EEP200200469A EE05644B1 EE 05644 B1 EE05644 B1 EE 05644B1 EE P200200469 A EEP200200469 A EE P200200469A EE P200200469 A EEP200200469 A EE P200200469A EE 05644 B1 EE05644 B1 EE 05644B1
Authority
EE
Estonia
Prior art keywords
hcg
recombinant
purifying
purified
purification
Prior art date
Application number
EEP200200469A
Other languages
English (en)
Estonian (et)
Inventor
Paradisi Gianfranco
Rossi Mara
Scaglia Laura
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE200200469A publication Critical patent/EE200200469A/xx
Publication of EE05644B1 publication Critical patent/EE05644B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200200469A 2000-02-22 2001-01-22 Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG EE05644B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22
PCT/EP2001/000665 WO2001062773A1 (fr) 2000-02-22 2001-01-22 PROCEDE DE PURIFICATION DE hCG ET hCG RECOMBINEE PURIFIEE PAR CETTE METHODE

Publications (2)

Publication Number Publication Date
EE200200469A EE200200469A (et) 2004-04-15
EE05644B1 true EE05644B1 (et) 2013-04-15

Family

ID=8167925

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200469A EE05644B1 (et) 2000-02-22 2001-01-22 Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG

Country Status (31)

Country Link
US (2) US7297777B2 (fr)
EP (2) EP1257564B1 (fr)
JP (1) JP4588960B2 (fr)
KR (1) KR100806911B1 (fr)
CN (1) CN100482679C (fr)
AT (1) ATE406378T1 (fr)
AU (2) AU783320B2 (fr)
BG (1) BG65807B1 (fr)
BR (1) BRPI0108556B8 (fr)
CA (1) CA2399020A1 (fr)
CY (1) CY1108460T1 (fr)
CZ (1) CZ303144B6 (fr)
DE (1) DE60135541D1 (fr)
DK (1) DK1257564T3 (fr)
EA (1) EA006605B1 (fr)
EE (1) EE05644B1 (fr)
ES (1) ES2307585T3 (fr)
HR (1) HRP20020650B1 (fr)
HU (2) HU1300063D0 (fr)
IL (2) IL151308A0 (fr)
ME (1) ME00296B (fr)
MX (1) MXPA02007871A (fr)
NO (1) NO328694B1 (fr)
PL (1) PL205149B1 (fr)
PT (1) PT1257564E (fr)
RS (1) RS50741B (fr)
SI (1) SI1257564T1 (fr)
SK (1) SK287146B6 (fr)
UA (2) UA86938C2 (fr)
WO (1) WO2001062773A1 (fr)
ZA (1) ZA200206109B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006605B1 (ru) * 2000-02-22 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО чХГ
ATE469912T1 (de) * 2004-10-04 2010-06-15 Novetide Ltd Gegenionenaustauschverfahren für peptide
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
WO2008007993A1 (fr) * 2006-07-11 2008-01-17 Koval, Anton Alexandrovich Utilisation d'une hormone chorionique ou lutéinisante destinée à la prévention ou au traitement de l'hypogonadisme lié à l'âge
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜促性腺激素的纯化方法
WO2012120535A2 (fr) * 2011-02-03 2012-09-13 Sanzyme Limited Composition contenant de la gonadotropine chorionique extrêmement purifiée, sa formulation et ses utilisations
PL2691119T3 (pl) 2011-03-31 2019-01-31 Ferring B.V. Preparat farmaceutyczny
WO2013102921A2 (fr) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - nouvelle modalité de traitement du diabète de type 2 (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜促性腺激素的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜促性腺激素冻干粉针剂及其制备方法
CN116063452A (zh) * 2023-01-03 2023-05-05 杭州浦泰生物科技有限公司 一种人绒毛膜促性腺激素高效纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3045539B2 (ja) * 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) * 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
CN1082368C (zh) * 1995-03-21 2002-04-10 应用研究系统Ars股份公司 人绒毛膜促性腺激素液体制剂
PT814841E (pt) 1995-03-21 2002-03-28 Applied Research Systems Formulacoes liquidas de hcg
BR9707589A (pt) * 1996-02-20 2000-01-04 Applied Research Systems Proteìna hìbrida, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica e processos para produzir proteìna hìbrida e para induzir maturação folicular.
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
WO1998056806A1 (fr) 1997-06-12 1998-12-17 The Regents Of The University Of California Proteine de coactivation de facteur de transcription, p/cip
CA2289665C (fr) * 1997-06-13 2005-08-09 Genentech, Inc. Recuperation de proteine par chromatographie suivie d'une filtration sur une couche chargee
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
EA006605B1 (ru) * 2000-02-22 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО чХГ

Also Published As

Publication number Publication date
WO2001062773A1 (fr) 2001-08-30
HUP0204231A2 (hu) 2003-03-28
EE200200469A (et) 2004-04-15
MEP38908A (en) 2011-02-10
EP1257564A1 (fr) 2002-11-20
KR20030001359A (ko) 2003-01-06
EA006605B1 (ru) 2006-02-24
BR0108556A (pt) 2003-01-28
NO328694B1 (no) 2010-04-26
MXPA02007871A (es) 2003-02-10
EP1257564B1 (fr) 2008-08-27
CN1404485A (zh) 2003-03-19
BG65807B1 (bg) 2009-12-31
EA200200892A1 (ru) 2003-02-27
ATE406378T1 (de) 2008-09-15
RS50741B (sr) 2010-08-31
YU60202A (sh) 2005-09-19
CZ303144B6 (cs) 2012-05-02
AU2006200059A1 (en) 2006-02-02
HK1052016A1 (zh) 2003-08-29
CA2399020A1 (fr) 2001-08-30
HRP20020650B1 (en) 2011-02-28
PT1257564E (pt) 2008-09-10
NO20023985L (no) 2002-08-21
HU1300063D0 (hu) 2003-03-28
AU783320B2 (en) 2005-10-13
ES2307585T3 (es) 2008-12-01
EP1752466A2 (fr) 2007-02-14
HRP20020650A2 (en) 2004-12-31
SI1257564T1 (sl) 2008-12-31
IL151308A (en) 2009-11-18
HUP0204231A3 (en) 2005-09-28
JP2003524015A (ja) 2003-08-12
EP1752466A3 (fr) 2012-10-10
JP4588960B2 (ja) 2010-12-01
CZ20022855A3 (cs) 2002-11-13
PL205149B1 (pl) 2010-03-31
CY1108460T1 (el) 2014-04-09
BG107000A (en) 2003-04-30
IL151308A0 (en) 2003-04-10
UA86938C2 (uk) 2009-06-10
DE60135541D1 (de) 2008-10-09
CN100482679C (zh) 2009-04-29
US20070299001A1 (en) 2007-12-27
NO20023985D0 (no) 2002-08-21
ZA200206109B (en) 2003-07-31
BRPI0108556B1 (pt) 2015-04-14
HU228935B1 (en) 2013-06-28
DK1257564T3 (da) 2008-10-06
UA78488C2 (en) 2007-04-10
PL357508A1 (en) 2004-07-26
US7297777B2 (en) 2007-11-20
KR100806911B1 (ko) 2008-02-22
BRPI0108556B8 (pt) 2021-05-25
SK12062002A3 (sk) 2002-12-03
US20030104553A1 (en) 2003-06-05
SK287146B6 (sk) 2010-01-07
AU2680401A (en) 2001-09-03
ME00296B (fr) 2011-05-10

Similar Documents

Publication Publication Date Title
EE05644B1 (et) Meetod hCG puhastamiseks ja selle meetodiga puhastatud rekombinantne hCG
EE200200464A (et) Meetod LH puhastamiseks
PL366364A1 (en) Process for producing peptides by using in vitrotranscription/translation system
PT98048A (pt) Metodo de tratamento de celulas cancerosas da bexiga utilizando proteinas hibridas, nomeadamente pe40 modificado ligado a tgf-alfa
WO2002018443A3 (fr) Anticorps monoclonal de recombinaison dirige contre les proteines contenant de la phosphotyrosine
BR0010677B1 (pt) processo de purificaÇço de gonadotropinas urinÁrias humanas a partir de gonadotropinas brutas.
BR9301641A (pt) Processo para produzir uma preparacao de fator viii,altamente purificada e uso
ES2161790T3 (es) Procedimiento de separacion y de purificacion de proteinas dependientes de la vitamina k.
ATE98257T1 (de) Methode zur reinigung von interferon.
Hearn et al. The Analysis of Insulin-Related Peptides by Reversed-Phase High-Performance Liquid Chromatography
RU94021724A (ru) Способ синтеза дез-гли1 0, /д - лей6/ - lh-rh-этиламида

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name